 |
|
 |
||
MediQuest Therapeutics is a privately held specialty pharmaceutical company headquartered in Bothell, Washington.MediQuest is a specialty pharmaceutical company developing first- and best- in-class topical therapies to treat patients suffering from inflammatory and infectious diseases. Using a proprietary drug delivery technology, MediQuest can deliver a topical therapy through thickened or diseased skin and nails. The Company's innovative treatment approach and proprietary drug delivery system have generated a robust late-stage clinical pipeline aimed at treating inflammatory/infectious diseases and satisfying unmet medical needs. For information about Raynauds, visit www.mqti.com/raynauds.
|
|
6/25/08: FDA Grants Priority Review for MediQuest’s Drug Application to treat Raynaud’s Disease 4/28/08: MediQuest Therapeutics Submits Drug Application to FDA to treat Raynaud's Disease Seattle Times 4/28/08: Mediquest asks for FDA approval of drug Raynauds info Scleroderma Foundation Raynaud's Association Raynaud's Group UK American College of Rheumatology American Academy of Dermatology |
| ©2008 Mediquest Therapeutics | ||